(Q38017938)

27 August 2017

title

An update on primary hyperoxaluria (English)

1 reference

27 August 2017

Bernd Hoppe

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

12 June 2012

1 reference

Nature Reviews Nephrology

27 August 2017

published in

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

467-475

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2012.113

27 August 2017

exact match

0 references

cites work

Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type 1: still challenging!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria--the German experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

The primary hyperoxalurias: an algorithm for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

International registry for primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: lack of relationship between genotype, enzymic phenotype, and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type 1 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type 2 without L-glycericaciduria: is the disease under-diagnosed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Mutations in DHDPSL are responsible for primary hyperoxaluria type III

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Peculiar morphology of stones in primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Urinary oxalate and glycolate excretion in healthy infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Clinical implications of mutation analysis in primary hyperoxaluria type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

[13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Intestinal transport of an obdurate anion: oxalate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Hyperoxaluria: a gut-kidney axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Management of primary hyperoxaluria: efficacy of oral citrate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Renal handling of citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Transplantation outcomes in primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Transplantation for primary hyperoxaluria in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Urine in clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Proteome of human calcium kidney stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria involving the liver and hepatic artery: images of an aggressive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria: from gene defects to designer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Changing pattern of primary hyperoxaluria in Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

The primary hyperoxalurias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Systemic oxalosis: pathognomonic renal and specific extrarenal findings on US and CT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Unusual painful sclerotic plaques on the legs of a patient with late diagnosis of primary hyperoxaluria type I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Molecular aetiology of primary hyperoxaluria type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Evidence of true genotype-phenotype correlation in primary hyperoxaluria type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Nephrocalcinosis and urolithiasis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Plasma Profiles and Dialysis Kinetics of Oxalate in Patients Receiving Hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Liver cell transplantation in severe infantile oxalosis--a potential bridging procedure to orthotopic liver transplantation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.113

Primary hyperoxaluria: genotype-phenotype correlation

31 March 2020

1 reference

12 December 2020

Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD

1 reference

12 December 2020

Regulatory aspects of oxalate secretion in enteric oxalate elimination.

1 reference

12 December 2020

Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes

1 reference

12 December 2020

The primary hyperoxalurias

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.113

1 reference

27 August 2017

1 reference